SCD and type 2 diabetes mellitus: Among participants with Cu/Zn ratios above the median, higher SCD1-18 activity was significantly associated with reduced T2D risk (HR = 0.74, 95% CI 0.61–0.90), whereas no association was observed in those with ratios below the median (HR = 1.05, 95% CI 0.90–1.23).